Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Total 13F shares
-
36,340,569
-
Share change
-
-679,196
-
Total reported value
-
$1,001,480,449
-
Price per share
-
$27.56
-
Number of holders
-
73
-
Value change
-
-$19,825,144
-
Number of buys
-
41
-
Number of sells
-
22
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q3 2021
As of 30 Sep 2021 Olema Pharmaceuticals, Inc. - Common Stock (OLMA) had 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,340,569 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Logos Global Management LP, Cormorant Asset Management, LP, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, VR Adviser, LLC, and CITADEL ADVISORS LLC.
This table shows 72 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.